Open access
Sep 2026
CRISPR-dCas13a-based electrochemical biosensor for sensitive detection of miR-331-5p as a potential biomarker of Parkinson's disease.
Triplicate spike-recovery measurements in healthy human serum and storage-stability studies supported the analytical applicability and reproducibility of the CRISPR-dCas13a/EIS-based proof-of-concept analytical platform for miR-331-5p detection.
İrem Yiğit, Burcu Azrak, Z. Uygun
· Analytical Biochemistry · 0 citations